Bone Marrow TransplantationTransplantation, HomologousHematopoietic Stem Cell TransplantationBone MarrowBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousStem CellsStem Cell TransplantationTransplantation ConditioningWhole-Body IrradiationHematopoietic Stem CellsTissue DonorsGraft SurvivalAnemia, AplasticHematologic NeoplasmsLeukemiaBone and BonesTransplantation ChimeraHistocompatibility TestingBusulfanHistocompatibilityKidney TransplantationTreatment OutcomeBone Marrow PurgingLiver TransplantationTransplantationImmunosuppressive AgentsRecurrenceCyclophosphamideCytomegalovirus InfectionsCombined Modality TherapyTime FactorsGraft RejectionTransplantation, IsogeneicHematopoiesisRetrospective StudiesHepatic Veno-Occlusive DiseaseLeukemia, Myelogenous, Chronic, BCR-ABL PositivePeripheral Blood Stem Cell TransplantationLeukemia, Myeloid, AcuteMice, Inbred C57BLImmunocompromised HostPrecursor Cell Lymphoblastic Leukemia-LymphomaBone Marrow DiseasesRemission InductionCell DifferentiationImmunosuppressionHematologic DiseasesOpportunistic InfectionsAcute DiseaseHeart TransplantationSurvival AnalysisLymphocyte DepletionTransplantation ImmunologyRadiation ChimeraLeukocyte TransfusionLeukemia, MyeloidEmbryonic Stem CellsLymphoma, Non-HodgkinHLA AntigensCyclosporineBone Marrow ExaminationMyelodysplastic SyndromesAdult Stem CellsT-LymphocytesMultiple MyelomaHematopoietic Stem Cell MobilizationSurvival RateLung TransplantationAntineoplastic Combined Chemotherapy ProtocolsFollow-Up StudiesMesenchymal Stem Cell TransplantationBone RemodelingColony-Forming Units AssayGraft vs Leukemia EffectFatal OutcomeCord Blood Stem Cell TransplantationBone Marrow NeoplasmsAntigens, CD34AspergillosisGraft vs Host ReactionOrgan TransplantationFlow CytometryCells, CulturedMycosesChimeraMelphalanSevere Combined ImmunodeficiencyGranulocyte Colony-Stimulating FactorDisease-Free SurvivalCytomegalovirusChimerismLymphocyte TransfusionTransplantsPluripotent Stem CellsSalvage TherapyCell TransplantationStem Cell NichePrognosis